Retraction
Research Progress of B-Cell Lymphoma/Leukemia-2 Inhibitor Combined with Azacytidine in the Targeted Therapy of Acute Myeloid Leukemia
Paper Information
Record ID:
56372
Author(s):
Publication Date:
October 08, 2022
Retraction Date:
October 04, 2023
(2.1 years years ago)
Subjects:
Institution:
Department of Oncology and Hematology, People's Hospital of Leshan, Leshan 614000, Sichuan Province, ChinaCountry:
🇨🇳 ChinaArticle Type:
Publisher:
Hindawi
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
- Concerns/Issues About Data
- Concerns/Issues about Results and/or Conclusions
- Concerns/Issues about Referencing/Attributions
- Concerns/Issues with Peer Review
- Investigation by Journal/Publisher
- Investigation by Third Party
- Paper Mill
- Computer-Aided Content or Computer-Generated Content
- Unreliable Results and/or Conclusions
Nature of Retraction:
Retraction
Retraction Notice:
10.1155/2023/9837485Additional Notes:
See also: https://pubpeer.com/publications/3143CAAC10DEC4F584D2F49362D178
Citations (3)
3
Total Citations1
Post-Retraction(33.3%)
1
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
0
Within 1 year
0
After 2+ years
436
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Retracted: Research Progress of B‐Cell Lymphoma/Leukemia‐2 Inhibitor Combined with Azacytidine in the Targeted Therapy of Acute Myeloid Leukemia
Computational and Mathematical Methods in Medicine
Computational and Mathematical Methods in Medicine
Open Access
Published: Jan 2023
276 days before retraction
Quick Stats
Total Citations:
4
Years Since Retraction:
2.1 years
Open Access:
Yes
Last Checked:
Jul 24, 2025